FDA Approves Generic Version of Prostate Cancer Drug

Boston (DbTechNo) – The FDA have granted approval to Sun Pharmaceutical to sell a generic version of AstraZeneca Plc’s prostate cancer drug Casodex.

Sun Pharmaceutical is based in India, and had previously applied to the FDA for possible approval of the generic drug.

Generic drugs are gaining in popularity because they are much cheaper than the brand name version.

Prostate cancer is a tricky cancer to treat because it rarely exhibits symptoms in its early stage.

All men over the age of 50 are recommended to go for an annunal prostate exam to check for any signs of the disease.

Treatment options for prostate cancer range from surgery and drug therapy, to taking a wait and see approach.

• Pin It
• Share
• Tweet